Reduction of Lams-Related Adverse Events with Accumulating Experience in a Large-Volume Tertiary Referral Center.

ABSTRACT:

Background and aims

Lumen-apposing metal stents (LAMSs) are increasingly used both for on- and off-label indications. We continuously adapt our step-by-step protocol to optimize the safe deployment of LAMSs for the different indications. The aim of this study was to evaluate the impact of this approach over time.

Methods

We conducted a single-center study on consecutive patients who underwent LAMS placement for on- and off-label indications between June 2020 and June 2022. Endpoints included technical success, clinical success and adverse event rates. We compared the results with our previously published early experience with LAMSs (N = 61), between March 2018 and May 2020.

Results

This cohort consisted of 168 LAMSs in 153 patients. Almost half of them (47.6%) were pl

SUBMITTER: Stefanovic S 

PROVIDER: S-EPMC9917779 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature